MedPath

Bismuth subcitrate potassium

Generic Name
Bismuth subcitrate potassium
Brand Names
Pylera
Drug Type
Small Molecule
Chemical Formula
C12H8BiK5O14
CAS Number
880149-29-1
Unique Ingredient Identifier
BQE6KE1T4H

Overview

A bismuth compound used for peptic ulcer and gastro-oesophageal reflux disease (GORD).

Indication

For the treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD). Treatment of inflammatory and erosive-ulcerous diseases of gastric and duodenal mucosa: gastritis, ulcer disease of the stomach and duodenum, functional non-ulcerous dyspepsia, erosive duodenitis, post-operative inflammatory and erosive changes – anastomositis, peptic ulcer of anastomosis

Associated Conditions

  • Cough, Acute
  • Helicobacter Pylori Infection

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2019/04/24
Not Applicable
Terminated
Università degli Studi di Sassari

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Ingenus Pharmaceuticals, LLC
50742-283
ORAL
140 mg in 1 1
7/4/2023
H2-Pharma, LLC
61269-380
ORAL
140 mg in 1 1
10/19/2023
Par Pharmaceutical, Inc.
49884-151
ORAL
140 mg in 1 1
3/15/2023
Physicians Total Care, Inc.
54868-6151
ORAL
140 mg in 1 1
3/14/2011
H2-Pharma, LLC
61269-385
ORAL
140 mg in 1 1
5/31/2023
Allergan, Inc.
58914-601
ORAL
140 mg in 1 1
11/15/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.